gmail.com Aims To investigate the therapeutic effect of recombinant tissue plasminogen activator (r-tPA) in patients with refractory toxic anterior chamber segment syndrome after cataract surgery with ...

seed.net.tw An 81 year old man with a history of hypertension received intravenous recombinant tissue plasminogen activator (tPA) for right middle cerebral artery (MCA) infarction. He had not had ...

While the use of recombinant tissue plasminogen activator in accordance to licensed criteria has continuously risen, off-label use is also frequent. In this review the most important reasons to ...

Intravenous thrombolysis with tissue plasminogen activator (tPA) remains a cornerstone for achieving vascular recanalization in such patients; however, its therapeutic utility is limited, with only ...

No writing assistance was utilized in the production of this manuscript. Use of recombinant tissue plasminogen activator (alteplase) for treatment of acute ischemic stroke outside the criteria of ...

When frostbitten limbs warm up again, blood rushes back into the tissue. With that blood come compounds such as histamines ...

according to the Spurs — and was treated with a "tissue plasminogen activator (tPA)" drug, it would help limit the long-term impacts of the stoke by breaking up the blood clots (it is why ...

Intravenous thrombolysis or administration of alteplase, a recombinant tPA (tissue-type plasminogen activator) to dissolve the clot alone will not help such patients, because the drug can dissolve ...

Blogging Stroke highlights high-impact studies published in the journal Stroke. In addition to article summaries, Blogging Stroke includes interviews with authors of recently published Stroke articles ...

A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...